SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Antonio Facciorusso, Valentina Del Prete, Matteo Antonino, Viviana Neve, Annabianca Amoruso, Nicola Crucinio, Alfredo Di Leo, Michele Barone, Conditional survival analysis of hepatocellular carcinoma patients treated with radiofrequency ablation, Hepatology Research, 2015, 45, 2
  2. 2
    Laura M. Kulik, Attasit Chokechanachaisakul, Evaluation and Management of Hepatocellular Carcinoma, Clinics in Liver Disease, 2015, 19, 1, 23

    CrossRef

  3. 3
    Serkan Demirelli, Metin Erkilic, Ali Ozan Oner, Evrim Surer Budak, Seyda Gunduz, Ozhan Ozgur, Hakan Bozcuk, Hakki Timur Sindel, Adil Boz, Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres, Nuclear Medicine Communications, 2015, 36, 4, 340

    CrossRef

  4. 4
    Yogesh K. Chawla, Vijay Bodh, Portal Vein Thrombosis, Journal of Clinical and Experimental Hepatology, 2015,

    CrossRef

  5. 5
    Yukio Osaki, Hiroki Nishikawa, Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review, Hepatology Research, 2015, 45, 1
  6. 6
    Massimo Colombo, Angelo Sangiovanni, Treatment of hepatocellular carcinoma: beyond international guidelines, Liver International, 2015, 35,
  7. 7
    Edward W. Lee, Avnesh S. Thakor, Bashir A. Tafti, David M. Liu, Y90 Selective Internal Radiation Therapy, Surgical Oncology Clinics of North America, 2015, 24, 1, 167

    CrossRef

  8. 8
    Annagiulia Gramenzi, Rita Golfieri, Cristina Mosconi, Alberta Cappelli, Alessandro Granito, Alessandro Cucchetti, Sara Marinelli, Cinzia Pettinato, Virginia Erroi, Silvia Fiumana, Luigi Bolondi, Mauro Bernardi, Franco Trevisani, Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis, Liver International, 2015, 35, 3
  9. 9
    Alexander S. Pasciak, Austin C. Bourgeois, Yong C. Bradley, A Comparison of Techniques for 90Y PET/CT Image-Based Dosimetry Following Radioembolization with Resin Microspheres, Frontiers in Oncology, 2014, 4,

    CrossRef

  10. 10
    Nima Kokabi, James R. Galt, Minzhi Xing, Juan C. Camacho, Bruce J. Barron, David M. Schuster, Hyun S. Kim, A Simple Method for Estimating Dose Delivered to Hepatocellular Carcinoma after Yttrium-90 Glass-Based Radioembolization Therapy: Preliminary Results of a Proof of Concept Study, Journal of Vascular and Interventional Radiology, 2014, 25, 2, 277

    CrossRef

  11. 11
    Nima Kokabi, Juan C. Camacho, Minzhi Xing, Deqiang Qiu, Hiroumi Kitajima, Pardeep K. Mittal, Hyun S. Kim, Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable infiltrative hepatocellular carcinoma with portal vein thrombosis, Abdominal Imaging, 2014, 39, 5, 969

    CrossRef

  12. 12
    Bruno Sangro, Chemoembolization and radioembolization, Best Practice & Research Clinical Gastroenterology, 2014, 28, 5, 909

    CrossRef

  13. 13
    Valérie Vilgrain, Mohamed Abdel-Rehim, Annie Sibert, Maxime Ronot, Clinical studies in hepatocellular carcinoma, Future Oncology, 2014, 10, 15s, 13

    CrossRef

  14. 14
    Khairuddin Memon, Laura M. Kulik, Robert J. Lewandowski, Edward Wang, Jonathan Wang, Robert K. Ryu, Ryan Hickey, Michael Vouche, Talia Baker, Daniel Ganger, Vanessa L. Gates, Ali Habib, Mary F. Mulcahy, Riad Salem, Comparative Study of Staging Systems for Hepatocellular Carcinoma in 428 Patients Treated with Radioembolization, Journal of Vascular and Interventional Radiology, 2014, 25, 7, 1056

    CrossRef

  15. 15
    Nassir Rostambeigi, Adrienne S. Dekarske, Erin E. Austin, Jafar Golzarian, Erik N. Cressman, Cost Effectiveness of Radioembolization Compared with Conventional Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma, Journal of Vascular and Interventional Radiology, 2014, 25, 7, 1075

    CrossRef

  16. 16
    Shyam M. Srinivas, Navin Natarajan, Joshua Kuroiwa, Sean Gallagher, Elie Nasr, Shetal N. Shah, Frank P. DiFilippo, Nancy Obuchowski, Bana Bazerbashi, Naichang Yu, Gordon McLennan, Determination of Radiation Absorbed Dose to Primary Liver Tumors and Normal Liver Tissue Using Post-Radioembolization 90Y PET, Frontiers in Oncology, 2014, 4,

    CrossRef

  17. 17
    Bruno Sangro, Evidence-based integration of selective internal radiation therapy into hepatocellular carcinoma management, Future Oncology, 2014, 10, 15s, 7

    CrossRef

  18. 18
    Haruyuki Takaki, Koichiro Yamakado, Masakatsu Tsurusaki, Taku Yasumoto, Yasutaka Baba, Yoshiaki Narimatsu, Masashi Shimohira, Masato Yamaguchi, Kunihiro Matsuo, Yoshitaka Inaba, Koji Mikami, Ryohei Watanabe, Norifumi Nishida, Hiroshi Anai, Hideaki Kakizawa, Shozo Hirota, Hepatic arterial infusion chemotherapy with fine-powder cisplatin and iodized-oil suspension in patients with intermediate-stage and advanced-stage (Barcelona Clinic Liver Cancer stage-B or stage-C) hepatocellular carcinoma: multicenter phase-II clinical study, International Journal of Clinical Oncology, 2014,

    CrossRef

  19. 19
    Andrew J. Page, David C. Cosgrove, Benjamin Philosophe, Timothy M. Pawlik, Hepatocellular Carcinoma, Surgical Oncology Clinics of North America, 2014, 23, 2, 289

    CrossRef

  20. 20
    Bruno C. Odisio, Michael J. Wallace, Image-Guided Interventions in Oncology, Surgical Oncology Clinics of North America, 2014, 23, 4, 937

    CrossRef

  21. 21
    Carlo Spreafico, Carlo Morosi, Marco Maccauro, Raffaele Romito, Rodolfo Lanocita, Enrico M. Civelli, Carlo Sposito, Sherrie Bhoori, Carlo Chiesa, Laura F. Frigerio, Alice Lorenzoni, Tommaso Cascella, Alfonso Marchianò, Vincenzo Mazzaferro, Intrahepatic Flow Redistribution in Patients Treated with Radioembolization, CardioVascular and Interventional Radiology, 2014,

    CrossRef

  22. 22
    Bruno Sangro, Liver function considerations for post-selective internal radiation therapy resection (hepatocellular carcinoma and metastatic colorectal cancer), Future Oncology, 2014, 10, 15s, 57

    CrossRef

  23. 23
    P. Fitzmorris, M. Shoreibah, B. S. Anand, A. K. Singal, Management of hepatocellular carcinoma, Journal of Cancer Research and Clinical Oncology, 2014,

    CrossRef

  24. 24
    Myeong Jun Song, Si Hyun Bae, Newer treatments for advanced hepatocellular carcinoma, The Korean Journal of Internal Medicine, 2014, 29, 2, 149

    CrossRef

  25. 25
    Andrew S. Kennedy, Bruno Sangro, Nonsurgical Treatment for Localized Hepatocellular Carcinoma, Current Oncology Reports, 2014, 16, 3

    CrossRef

  26. 26
    Antonio Facciorusso, Valentina Del Prete, Matteo Antonino, Nicola Crucinio, Viviana Neve, Alfredo Di Leo, Brian I. Carr, Michele Barone, Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation, Digestive and Liver Disease, 2014, 46, 11, 1014

    CrossRef

  27. 27
    Laura Kulik, Michael Vouche, Sean Koppe, Robert J. Lewandowski, Mary F. Mulcahy, Daniel Ganger, Ali Habib, Jennifer Karp, Patrice Al-Saden, Mario Lacouture, Jonathan Cotliar, Michael Abecassis, Talia Baker, Riad Salem, Prospective randomized pilot study of Y90+/−sorafenib as bridge to transplantation in hepatocellular carcinoma, Journal of Hepatology, 2014, 61, 2, 309

    CrossRef

  28. 28
    Valérie Vilgrain, Mohamed Abdel-Rehim, Annie Sibert, Maxime Ronot, Rachida Lebtahi, Laurent Castéra, Gilles Chatellier, Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial, Trials, 2014, 15, 1, 474

    CrossRef

  29. 29
    Jöerg Friedrich Schlaak, Radioembolization with yttrium-90 glass microspheres for patients with hepatocellular carcinoma: a review, Hepatic Oncology, 2014, 1, 4, 387

    CrossRef

  30. 30
    Ryan M Hickey, Robert J Lewandowski, Riad Salem, Rationale of transcatheter intra-arterial therapies of hepatic cancers, Hepatic Oncology, 2014, 1, 3, 285

    CrossRef

  31. 31
    J. Schelhorn, J. Theysohn, J. Ertle, J.F. Schlaak, S. Mueller, A. Bockisch, T. Lauenstein, Selective internal radiation therapy of hepatic tumours: Is coiling of the gastroduodenal artery always beneficial?, Clinical Radiology, 2014, 69, 5, e216

    CrossRef

  32. 32
    Antonio Facciorusso, Valentina Del Prete, Matteo Antonino, Viviana Neve, Nicola Crucinio, Alfredo Di Leo, Brian I Carr, Michele Barone, Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation, Journal of Gastroenterology and Hepatology, 2014, 29, 11
  33. 33
    Rita Golfieri, SIR-Spheres yttrium-90 radioembolization for the treatment of unresectable liver cancers, Hepatic Oncology, 2014, 1, 3, 265

    CrossRef

  34. 34
    Siddharth A. Padia, Sharon W. Kwan, Bahman Roudsari, Wayne L. Monsky, Andrew Coveler, William P. Harris, Superselective Yttrium-90 Radioembolization for Hepatocellular Carcinoma Yields High Response Rates with Minimal Toxicity, Journal of Vascular and Interventional Radiology, 2014, 25, 7, 1067

    CrossRef

  35. 35
    Andrew Yu-Keat Khor, Ying Toh, John Carson Allen, David Chee-Eng Ng, Yung-Hsiang Kao, Guili Zhu, Su-Pin Choo, Richard Hoau-Gong Lo, Kiang-Hiong Tay, Jin-Yao Teo, Brian Kim-Poh Goh, Mark Christiaan Burgmans, Farah Gillian Irani, Anthony Soon-Whatt Goh, Pierce Kah-Hoe Chow, Survival and pattern of tumor progression with yttrium-90 microsphere radioembolization in predominantly hepatitis B Asian patients with hepatocellular carcinoma, Hepatology International, 2014, 8, 3, 395

    CrossRef

  36. 36
    Philip Chong-Hei Kwok, Kwong Chuen Leung, Moon Tong Cheung, Ting Wa Lam, Lok Tin Szeto, Sandas Qi-Hua Chou, Nam Hung Chia, Cheuk Man Tong, Pui Kei Yuen, Chun Hung Cheung, Chun Key Law, Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres, Journal of Gastroenterology and Hepatology, 2014, 29, 11
  37. 37
    Carlo Spreafico, Marco Maccauro, Vincenzo Mazzaferro, Carlo Chiesa, The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE), European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41, 4, 634

    CrossRef

  38. 38
    Lidia Strigari, Mark Konijnenberg, Carlo Chiesa, Manuel Bardies, Yong Du, Katarina Sjögreen Gleisner, Michael Lassmann, Glenn Flux, The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy, European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41, 10, 1976

    CrossRef

  39. 39
    Jeet Minocha, Riad Salem, Robert J. Lewandowski, Transarterial Chemoembolization and Yittrium-90 for Liver Cancer and Other Lesions, Clinics in Liver Disease, 2014, 18, 4, 877

    CrossRef

  40. 40
    Alejandro Forner, Marine Gilabert, Jordi Bruix, Jean-Luc Raoul, Treatment of intermediate-stage hepatocellular carcinoma, Nature Reviews Clinical Oncology, 2014, 11, 9, 525

    CrossRef

  41. 41
    Henry H. Tam, Adil Al-Nahhas, Treatment of liver tumours with yttrium radioembolisation, Clinical and Translational Imaging, 2014, 2, 2, 165

    CrossRef

  42. 42
    Irene Bargellini, Francesco Florio, Rita Golfieri, Maurizio Grosso, Dario Luca Lauretti, Roberto Cioni, Trends in Utilization of Transarterial Treatments for Hepatocellular Carcinoma: Results of a Survey by the Italian Society of Interventional Radiology, CardioVascular and Interventional Radiology, 2014, 37, 2, 438

    CrossRef

  43. 43
    Laura Kulik, Riad Salem, Yttrium-90 radioembolization for hepatocellular carcinoma in hepatitis B: commentary on a 103-patient Asian cohort, Hepatology International, 2014, 8, 3, 304

    CrossRef

  44. 44
    Akshat Saxena, Baerbel Meteling, Jada Kapoor, Sanjeev Golani, Mark Danta, David L. Morris, Lourens Bester, Yttrium-90 radioembolization is a safe and effective treatment for unresectable hepatocellular carcinoma: A single centre experience of 45 consecutive patients, International Journal of Surgery, 2014, 12, 12, 1403

    CrossRef

  45. 45
    E. Garin, L. Lenoir, J. Edeline, S. Laffont, H. Mesbah, P. Porée, L. Sulpice, K. Boudjema, M. Mesbah, A. Guillygomarc’h, E. Quehen, M. Pracht, J. L. Raoul, B. Clement, Y. Rolland, E. Boucher, Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept, European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40, 7, 1057

    CrossRef

  46. 46
    Rita Golfieri, Josè Ignacio Bilbao, Livio Carpanese, Roberto Cianni, Daniele Gasparini, Samer Ezziddin, Philipp Marius Paprottka, Francesco Fiore, Alberta Cappelli, Macarena Rodriguez, Giuseppe Maria Ettorre, Adelchi Saltarelli, Onelio Geatti, Hojjat Ahmadzadehfar, Alexander R. Haug, Francesco Izzo, Emanuela Giampalma, Bruno Sangro, Giuseppe Pizzi, Ermanno Notarianni, Alessandro Vit, Kai Wilhelm, Tobias F. Jakobs, Secondo Lastoria, Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma, Journal of Hepatology, 2013, 59, 4, 753

    CrossRef

  47. 47
    Daniel Shouval, Focus, Journal of Hepatology, 2013, 59, 4, 643

    CrossRef

  48. 48
    Marco Maccauro, Alice Lorenzoni, Giuseppe Boni, Carlo Chiesa, Carlo Spreafico, Raffaele Romito, Vincenzo Mazzaferro, Ettore Seregni, Multiagent imaging of liver tumors with reference to intra-arterial radioembolization, Clinical and Translational Imaging, 2013, 1, 6, 423

    CrossRef

  49. 49
    Luigi Bolondi, Fabio Piscaglia, Yttrium 90 radioembolization: The horizon is changing for patients with intermediate and advanced hepatocellular carcinoma, Hepatology, 2013, 57, 5